Investor profile
Vesalius Biocapital III has backed 4 European tech companies across 4 funding rounds between 2018 and 2024, joining rounds totalling €83M. Most active in Healthtech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| CatalYm | Germany | 1 | €50M |
| Topas Therapeutics | Germany | 1 | €18M |
| tonic app | Portugal | 1 | €11M |
| Sword Health | Portugal | 1 | €3.7M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| CatalYm | Series C | €50M | 2022-11 |
| Topas Therapeutics | Series B | €18M | 2021-07 |
| tonic app | Series A | €11M | 2024-03 |
| Sword Health |
| Other |
| €3.7M |
| 2018-02 |
